APEPTICO - Innovation in peptide drugs

SOLNATIDE: Read the most exciting news related to the exploration of safety, tolerability and clinical efficacy of SOLNATIDE IMP in patients infected with the 2019 new Coronavirus (SARS-CoV-2)

 

zurück